| Analysis | Metabolite Name | Measured Value | Units | Sample source | Factor |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 59974 | Raw Peak Area | Caecal Contents | GF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 68213 | Raw Peak Area | Caecal Contents | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 70974 | Raw Peak Area | Caecal Contents | ColGF_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 81306 | Raw Peak Area | Caecal Contents | GF_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 91758 | Raw Peak Area | Caecal Contents | GF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 99361 | Raw Peak Area | Caecal Contents | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 100212 | Raw Peak Area | Caecal Contents | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 101246 | Raw Peak Area | Caecal Contents | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 104543 | Raw Peak Area | Caecal Contents | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 106763 | Raw Peak Area | Caecal Contents | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 106861 | Raw Peak Area | Caecal Contents | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 108996 | Raw Peak Area | Caecal Contents | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 110284 | Raw Peak Area | Caecal Contents | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 113915 | Raw Peak Area | Caecal Contents | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 114343 | Raw Peak Area | Caecal Contents | GF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 115318 | Raw Peak Area | Caecal Contents | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 118133 | Raw Peak Area | Caecal Contents | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 118879 | Raw Peak Area | Caecal Contents | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 118905 | Raw Peak Area | Caecal Contents | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 122508 | Raw Peak Area | Caecal Contents | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 123704 | Raw Peak Area | Caecal Contents | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 127367 | Raw Peak Area | Caecal Contents | GF_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 128764 | Raw Peak Area | Caecal Contents | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 130990 | Raw Peak Area | Caecal Contents | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 134744 | Raw Peak Area | Caecal Contents | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 135650 | Raw Peak Area | Caecal Contents | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 136340 | Raw Peak Area | Caecal Contents | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 136997 | Raw Peak Area | Caecal Contents | Conv_0min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 146939 | Raw Peak Area | Caecal Contents | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 147801 | Raw Peak Area | Caecal Contents | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 150390 | Raw Peak Area | Caecal Contents | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 168722 | Raw Peak Area | Caecal Contents | ColGF_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 171129 | Raw Peak Area | Caecal Contents | ColGF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 171895 | Raw Peak Area | Caecal Contents | Conv_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 175377 | Raw Peak Area | Caecal Contents | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 190552 | Raw Peak Area | Caecal Contents | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 221825 | Raw Peak Area | Caecal Contents | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 230998 | Raw Peak Area | Caecal Contents | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 246306 | Raw Peak Area | Caecal Contents | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 255930 | Raw Peak Area | Caecal Contents | GF_Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 256096 | Raw Peak Area | Caecal Contents | Conv_45min |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | Raw Peak Area | Caecal Contents | ColGF_0min | |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | Raw Peak Area | Caecal Contents | ColGF_45min | |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | Raw Peak Area | Caecal Contents | ColGF_Pre | |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | Raw Peak Area | Caecal Contents | Conv_0min | |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | Raw Peak Area | Caecal Contents | GF_0min | |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | Raw Peak Area | Caecal Contents | GF_45min | |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | Raw Peak Area | Caecal Contents | GF_Pre |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|